Guy Singh

1.9k total citations
16 papers, 856 citations indexed

About

Guy Singh is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Guy Singh has authored 16 papers receiving a total of 856 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Organic Chemistry and 7 papers in Pharmacology. Recurrent topics in Guy Singh's work include Microbial Natural Products and Biosynthesis (7 papers), Carbohydrate Chemistry and Synthesis (6 papers) and Antibiotic Resistance in Bacteria (5 papers). Guy Singh is often cited by papers focused on Microbial Natural Products and Biosynthesis (7 papers), Carbohydrate Chemistry and Synthesis (6 papers) and Antibiotic Resistance in Bacteria (5 papers). Guy Singh collaborates with scholars based in United States and Canada. Guy Singh's co-authors include Peter J. Petersen, Youjun Yang, Anatoly Severin, Beth A. Rasmussen, Tarek S. Mansour, Marshall M. Siegel, Leonard A. McDonald, William Hu, Guy T. Carter and R. Thomas Williamson and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Bacteriology and Journal of Medicinal Chemistry.

In The Last Decade

Guy Singh

16 papers receiving 808 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guy Singh United States 13 523 381 189 133 111 16 856
Astrid Zervosen Belgium 21 543 1.0× 405 1.1× 146 0.8× 122 0.9× 239 2.2× 40 1.0k
Martin A. Shapiro United States 15 557 1.1× 399 1.0× 185 1.0× 159 1.2× 189 1.7× 30 993
Yanan Hu United States 11 682 1.3× 392 1.0× 200 1.1× 87 0.7× 97 0.9× 16 1.0k
Ravindranadh V. Somu United States 8 459 0.9× 227 0.6× 115 0.6× 196 1.5× 62 0.6× 8 707
Stephen J. Gracheck United States 17 468 0.9× 304 0.8× 148 0.8× 155 1.2× 249 2.2× 25 891
Martina Hrast Slovenia 20 566 1.1× 367 1.0× 89 0.5× 99 0.7× 136 1.2× 55 892
Folkert Reck United States 22 1.0k 2.0× 723 1.9× 150 0.8× 124 0.9× 245 2.2× 50 1.5k
Miha Kotnik Slovenia 12 435 0.8× 177 0.5× 85 0.4× 80 0.6× 136 1.2× 17 650
Riley L. Svec United States 6 351 0.7× 239 0.6× 137 0.7× 85 0.6× 258 2.3× 7 812
Susan E. Knudson United States 20 539 1.0× 472 1.2× 87 0.5× 292 2.2× 142 1.3× 24 1.0k

Countries citing papers authored by Guy Singh

Since Specialization
Citations

This map shows the geographic impact of Guy Singh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guy Singh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guy Singh more than expected).

Fields of papers citing papers by Guy Singh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guy Singh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guy Singh. The network helps show where Guy Singh may publish in the future.

Co-authorship network of co-authors of Guy Singh

This figure shows the co-authorship network connecting the top 25 collaborators of Guy Singh. A scholar is included among the top collaborators of Guy Singh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guy Singh. Guy Singh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Mansour, Tarek S., Craig E. Caufield, Beth A. Rasmussen, et al.. (2007). Naphthyl Tetronic Acids as Multi‐Target Inhibitors of Bacterial Peptidoglycan Biosynthesis. ChemMedChem. 2(10). 1414–1417. 38 indexed citations
2.
Gilbert, A., Amedeo Failli, Youjun Yang, et al.. (2006). Pyrazolidine-3,5-diones and 5-Hydroxy-1H-pyrazol-3(2H)-ones, Inhibitors of UDP-N-acetylenolpyruvyl Glucosamine Reductase. Journal of Medicinal Chemistry. 49(20). 6027–6036. 85 indexed citations
3.
Yang, Youjun, Anatoly Severin, Rajiv Chopra, et al.. (2006). 3,5-Dioxopyrazolidines, Novel Inhibitors of UDP- N - Acetylenolpyruvylglucosamine Reductase (MurB) with Activity against Gram-Positive Bacteria. Antimicrobial Agents and Chemotherapy. 50(2). 556–564. 68 indexed citations
4.
Antane, Schuyler, Craig E. Caufield, William Hu, et al.. (2005). Pulvinones as bacterial cell wall biosynthesis inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(1). 176–180. 58 indexed citations
5.
Kutterer, Kristina M. K., Guy Singh, Youjun Yang, et al.. (2005). 4-Alkyl and 4,4′-dialkyl 1,2-bis(4-chlorophenyl)pyrazolidine-3,5-dione derivatives as new inhibitors of bacterial cell wall biosynthesis. Bioorganic & Medicinal Chemistry Letters. 15(10). 2527–2531. 54 indexed citations
6.
McAleese, Fionnuala, Ellen Murphy, Timothy Babinchak, et al.. (2005). Use of Ribotyping To Retrospectively Identify Methicillin-Resistant Staphylococcus aureus Isolates from Phase 3 Clinical Trials for Tigecycline That Are Genotypically Related to Community-Associated Isolates. Antimicrobial Agents and Chemotherapy. 49(11). 4521–4529. 25 indexed citations
7.
Kutterer, Kristina M. K., Guy Singh, Youjun Yang, et al.. (2005). 4‐Alkyl and 4,4′‐Dialkyl 1,2‐Bis(4‐chlorophenyl)pyrazolidine‐3,5‐dione Derivatives as New Inhibitors of Bacterial Cell Wall Biosynthesis.. ChemInform. 36(38). 2 indexed citations
8.
Ruzin, Alexey, Guy Singh, Anatoly Severin, et al.. (2004). Mechanism of Action of the Mannopeptimycins, a Novel Class of Glycopeptide Antibiotics Active against Vancomycin-Resistant Gram-Positive Bacteria. Antimicrobial Agents and Chemotherapy. 48(3). 728–738. 74 indexed citations
9.
Yamashita, Ayako, Peter J. Petersen, Beth A. Rasmussen, et al.. (2003). Muraymycins, novel peptidoglycan biosynthesis inhibitors: synthesis and SAR of their analogues. Bioorganic & Medicinal Chemistry Letters. 13(19). 3345–3350. 57 indexed citations
10.
Francisco, Gerardo D., Zhong Li, J. Donald Albright, et al.. (2003). Phenyl thiazolyl urea and carbamate derivatives as new inhibitors of bacterial cell-wall biosynthesis. Bioorganic & Medicinal Chemistry Letters. 14(1). 235–238. 64 indexed citations
11.
Li, Zhong, Gerardo D. Francisco, William Hu, et al.. (2003). 2-Phenyl-5,6-dihydro-2H-thieno[3,2-c]pyrazol-3-ol derivatives as new inhibitors of bacterial cell wall biosynthesis. Bioorganic & Medicinal Chemistry Letters. 13(15). 2591–2594. 32 indexed citations
12.
Lin, Yang‐I, Zhong Li, Gerardo D. Francisco, et al.. (2002). Muraymycins, novel peptidoglycan biosynthesis inhibitors: semisynthesis and SAR of Their derivatives. Bioorganic & Medicinal Chemistry Letters. 12(17). 2341–2344. 52 indexed citations
13.
Ruzin, Alexey, Anatoly Severin, Frank V. Ritacco, et al.. (2002). Further Evidence that a Cell Wall Precursor [C 55 -MurNAc-(Peptide)-GlcNAc] Serves as an Acceptor in a Sorting Reaction. Journal of Bacteriology. 184(8). 2141–2147. 71 indexed citations
14.
McDonald, Leonard A., Laurel R. Barbieri, Guy T. Carter, et al.. (2002). Structures of the Muraymycins, Novel Peptidoglycan Biosynthesis Inhibitors.. ChemInform. 33(52). 217–217. 1 indexed citations
15.
McDonald, Leonard A., Laurel R. Barbieri, Guy T. Carter, et al.. (2002). Structures of the Muraymycins, Novel Peptidoglycan Biosynthesis Inhibitors. Journal of the American Chemical Society. 124(35). 10260–10261. 174 indexed citations
16.
Singh, Guy. (2000). Freedom Without Compromise: Creating a Secure Environment on the Move. Computer Fraud & Security. 2000(12). 11–13. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026